Stonegate Investment Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Stonegate Investment Group's LLY Position: Q3 2025 in Review
Stonegate Investment Group reduced its Eli Lilly (LLY) stake by 2.9% in Q3 2025, selling an estimated $1.25M and leaving 55,896 shares worth $42.6M. The position accounts for 0.99% of the portfolio, ranked #34.
Stonegate Investment Group first reported a position in LLY in Q4 2021 and has held it in 16 quarters since. The position peaked at $50.8M in Q2 2024. 3,897 funds tracked by Wall St. Rank hold LLY as of Q3 2025.
- Stonegate Investment Group held 55,896 shares of Eli Lilly worth $42.6M as of Q3 2025.
- Stonegate Investment Group sold 1,677 Eli Lilly shares in Q3 2025, an estimated $1.25M.
- Eli Lilly made up 0.99% of Stonegate Investment Group's portfolio in Q3 2025, its #34 holding.
- Stonegate Investment Group first reported a position in Eli Lilly in Q4 2021 and has held it in 16 quarters since.
- Stonegate Investment Group's Eli Lilly position peaked at $50.8M in Q2 2024.
- 3,897 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2025.
Based on Stonegate Investment Group's 13F filing for Q3 2025, filed 3 Nov 2025.